Vericel (VCEL) Earnings Date & Reports

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

VCEL is expected to report earnings to fall 135.21% to -13 cents per share on May 07

Q1'25

Est.

$-0.13

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.03

Q2'24

Missed

by $0.01

Q1'24

Beat

by $0.03

The last earnings report on February 27 showed earnings per share of 37 cents, beating the estimate of 30 cents. With 182.32K shares outstanding, the current market capitalization sits at 2.22B.

View a ticker or compare two or three

Compare

VCEL